DALAL ANUPAM received a stock award from WHITEHAWK THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/30/2026ACC: 0001602474-26-000004
+1.31M
Net shares
Net buyer
$5.00M
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.31M acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+1.28M
Price / share
$3.92
Trade value
$5M
% of position
37.4%
5/14/2026
3.41M→4.69M
Total
Net shares
+1.28M
Net value
$5M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/14/2026 | A · Award | +1.28M | $3.92 | $5M | 37.4% | 3.41M | 4.69M |
| Total | +1.28M | $5M | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
38.04K shares
Shares
+38.04K
Strike price
4.16
Held after
38.04K
Exercisable
—
6/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock38.04K shares | 6/12/2026 | A · Award | +38.04K | 4.16 | — | 38.04K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned1.13K
Total
1.13K direct1.13K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.13K | Direct |
| Total | 1.13K | 1.13K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported